Table 2 Clinical and laboratory evaluation of patients with rheumatoid arthritis

Disease duration in years

9.50 (5–15)

Patient global assessment

50 (20–70)

Physician global assessment

40 (17.5–60)

DAS 28

 • Mean ± SD (range)

4.65 ± 1.66 (1.60–7.97)

  ▪ Low disease activity

2

6.7%

  ▪ Moderate disease activity

10

33.3%

  ▪ High disease activity

14

46.7%

  ▪ Remission

4

13.3%

White blood cell count (× 10³/mm³)

6.90 ± 2.48

Neutrophils absolute count (× 10³/mm³)

3.70 (2.47–5.81)

Lymphocytes absolute count (× 10³/mm³)

2.05 (1.42–3.02)

Neutrophils lymphocyte ratio

2.23 ± 0.282

Hemoglobin (g/dl)

11.55 ± 1.52

Platelets (× 10³/µl)

315.20 ± 82.92

Aspartate transaminase (U/L)

17.740 ± 4.50

Alanine transaminase (U/L)

15.72 ± 4.70

Serum albumin (g/l)

40.96 ± 6.62

Blood urea nitrogen (mmol/L)

3.63 ± 1.24

Serum creatinine (umol/l)

0.73 ± 0.23

First hr. ESR (mm/h)

31.0 (17.50–45.0)

Rheumatoid factor

  ▪ Positive

27(90%)

  ▪ Negative

3 (10%)